Steps from where dozens of young immigrant Jewish and Italian women died when a fire erupted in the locked sweatshop, 60 Cornell students, faculty, staff and alumni gathered Oct. 11 to honor the legacy of the Triangle Shirtwaist Factory tragedy.
Seventeen individuals and three teams of Cornell employees received President's Awards for Employee Excellence in seven categories, highlighting the achievements of staff and faculty who excel in their roles.
A drug currently in clinical trials as a cancer therapy can also stimulate pancreatic beta cells to secrete insulin, revealing a previously unknown mechanism for insulin regulation in Type 2 diabetes, according to a new study by Weill Cornell Medicine investigators.
Resilient “superfruits” could benefit New York growers by diversifying their crops with native berries and appeal to consumers by offering nutritious new fruit choices.
Cornell chemists have developed a technique that allows them to image polymerization catalysis reactions at single-monomer resolution, key in discovering the molecular composition of a synthetic polymer.
After service in the military, Chris Brunkhorst and Caleb Jones sought new outlets to channel their discipline and their commitment to helping others – and they both found it in neuroscience.
Researchers at Weill Cornell Medicine have uncovered a novel route to stimulate the growth of healthy insulin-producing pancreatic beta cells in a preclinical model of diabetes. The findings hold promise for future therapeutics that will improve the lives of individuals with Type 2 diabetes – a condition that affects more than 500 million people worldwide.
A special type of cell, called an osteocyte, may hold the key to some of the mysteries of osteoporosis. A research group led by Karl Lewis, assistant professor of biomedical engineering, is studying osteocytes in unique new ways.
The FDA has approved tirzepatide – which will be sold under the brand name Zepbound – to treat overweight and obesity. It’s the latest entrant into a field of powerful new drugs that includes Ozempic and Wegovy.
Siddharth Kara, award-winning author and anti-slavery activist, will discuss the immense toll cobalt mining has had on the people and environment of the Democratic Republic of the Congo at noon on Friday, November 10.
